Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Understanding inorganic pyrophosphate metabolism: toward prevention of calcium pyrophosphate dihydrate crystal deposition.

× No keyword cloud information.

23 in total

1. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.

Authors: M Camerlain; D J McCarty; D C Silcox; A Jung
Journal: J Clin Invest Date: 1975-06 Impact factor: 14.808

2. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout.

Authors: D C Silcox; D J McCarty
Journal: J Lab Clin Med Date: 1974-04

3. Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma.

Authors: R D Altman; O E Muniz; J C Pita; D S Howell
Journal: Arthritis Rheum Date: 1973 Mar-Apr

4. Cartilage nucleoside triphosphate (NTP) pyrophosphohydrolase. I. Identification as an ecto-enzyme.

Authors: L M Ryan; R L Wortmann; B Karas; D J McCarty
Journal: Arthritis Rheum Date: 1984-04

5. Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage.

Authors: U Olmez; L M Ryan; I V Kurup; A K Rosenthal
Journal: Osteoarthritis Cartilage Date: 1994-09 Impact factor: 6.576

6. Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease.

Authors: L M Ryan; F Kozin; D J McCarty
Journal: Arthritis Rheum Date: 1979-08

7. Comparison of phosphohydrolase activities from articular cartilage in calcium pyrophosphate deposition disease and primary osteoarthritis.

Authors: J Tenenbaum; O Muniz; H R Schumacher; A E Good; D S Howell
Journal: Arthritis Rheum Date: 1981-03

8. Calcium pyrophosphate dihydrate crystal deposition disease: a review of the literature and a light and electron microscopic study of a case of the temporomandibular joint with numerous intracellular crystals in the chondrocytes.

Authors: L C Dijkgraaf; R S Liem; L G de Bont; G Boering
Journal: Osteoarthritis Cartilage Date: 1995-03 Impact factor: 6.576

9. Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture.

Authors: L M Ryan; H S Cheung; D J McCarty
Journal: Arthritis Rheum Date: 1981-12

10. A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles.

Authors: I Masuda; J Hamada; A L Haas; L M Ryan; D J McCarty
Journal: J Clin Invest Date: 1995-02 Impact factor: 14.808

6 in total

1. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.

Authors: Yingchi Yang; Jun Cai; Jie Yin; Dong Wang; Zhigang Bai; Jun Zhang; Kangli Wang; Guanzhen Yu; Zhongtao Zhang
Journal: Int J Clin Exp Pathol Date: 2015-10-01

2. Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate.

Authors: G S Makowski; M L Ramsby
Journal: Inflammation Date: 1999-08 Impact factor: 4.092

Review 3. Pathophysiology of articular chondrocalcinosis--role of ANKH.

Authors: Abhishek Abhishek; Michael Doherty
Journal: Nat Rev Rheumatol Date: 2010-11-23 Impact factor: 20.543

Review 4. Crystal deposition and osteoarthritis.

Authors: N Olmez; H R Schumacher
Journal: Curr Rheumatol Rep Date: 1999-12 Impact factor: 4.592

5. Differential effect of calcium phosphate and calcium pyrophosphate on binding of matrix metalloproteinases to fibrin: comparison to a fibrin-binding protease from inflammatory joint fluids.

Authors: G S Makowski; M L Ramsby
Journal: Clin Exp Immunol Date: 2004-04 Impact factor: 4.330

6. Systematic Overview of Solid Particles and Their Host Responses.

Authors: Fei Shu; Yan Shi
Journal: Front Immunol Date: 2018-05-28 Impact factor: 7.561

6 in total